Controversies in the Management of the Patent Ductus Arteriosus

Rochester, NY US
December 9, 2019

This activity is designed to provide an overview of literature to guide treatment selection and timing for the management of PDA. With a better understanding of the efficacy and toxicities of the treatment options, clinicians may make educated decisions to select optimal treatment for their patient.

Target Audience

  • Pharmacists

Learning Objectives

Pharmacist learning objectives

  1. Describe the physiology and clinical significance of a patent ductus arteriosus
  2. Compare pharmacological agents used and management strategies for patent ductus arteriosus
  3. Identify indications and strategies for maintenance of a patent ductus arteriosus

Additional Information

Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 General CEU – Attendance
Course opens: 
12/09/2019
Course expires: 
01/22/2020
Event starts: 
12/09/2019 - 7:00am
Event ends: 
12/09/2019 - 8:00am
Cost:
$0.00
University of Rochester Medical Center
601 Elmwood Ave.
Rochester, NY 14642
United States
Relevant financial relationships: Planning committee members, reviewer and presenters have nothing to disclose
Planning committee members
Matthew O’Connell, PharmD
PGY-2 Pediatric Pharmacy Resident
University of Rochester Medical Center
 
Andrew Decker, PharmD, BCPPS
NICU Pharmacy Specialist
University of Rochester Medical Center
University of Rochester Medical Center
 
Course reviewer
Katrina Harper, PharmD, MBA, BCPS, DPLA
Senior Clinical Manager
Vizient
 
Presenter
Matthew O’Connell, PharmD
PGY-2 Pediatric Pharmacy Resident
University of Rochester Medical Center
Joint Accreditation Statement:
 
In support of improving patient care, this activity has been planned and implemented by Vizient, Inc. and University of Rochester Medical Center.  Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
 
Designation Statements:
 
PHARMACY
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-9999-19-232-L01-P
CEU
Vizient, Inc. will award CEUs to each participant who successfully completes this program. The CEU is a nationally recognized unit of measure for continuing education and training programs that meet certain criteria (1 contact hour = 0.1 CEU).

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 General CEU – Attendance

Price

Cost:
$0.00
Please login or register to take this course.